Back to Teaser

PE firms eye £10bn deal for British Ports

UK 4 min read
Author
Daniel Black

A controlling stake in the UK’s largest port operator is potentially for sale in a deal worth £10bn, according to Bloomberg.

Associated British Ports is attracting interest from KKR, Global Infrastructure Partners, and Brookfield Asset Management, among others. AB Ports has 21 facilities in the UK and handles about 25% of the country’s seaborne trade.

And in other news:

  • Blackstone and Tinicum agreed a £1.4bn deal for aerospace supplier Senior
  • Sixth Street bought a stake in Sunderland AFC Women
  • JPMorgan topped the dealmaker fee table in Q1

Thanks for reading, and connect with me on LinkedIn if you want to discuss how Ideals VDR can help with your next M&A deal.

Deal Tracker

Our weekly roundup of all the confirmed M&A deals in the UK.

TransactionSectorsBuyerBuyer’s advisorsSeller’s advisors
01

Evaaro acquired Keg Logistics and North Keg

Consumer

Evaaro

Not disclosed

Not disclosed

02

Moniepoint acquired Sumac Microfinance Bank Limited

Financial services

Moniepoint

Not disclosed

Not disclosed

03

Acrisure acquired MGA Vave from Canopius

Financial services

Acrisure

Not disclosed

Not disclosed

04

FourCentric acquired health transformation consultancy Clarity Consulting Associates

Healthcare/pharma

FourCentric

Not disclosed

Not disclosed

05

Acrisure UK acquired Confidas, Heathwoods, Marrs Brokers and Smith Greenfield

Insurance

Acrisure

Not disclosed

Not disclosed

06

Argos acquired Italian homecare manufacturer Relevi

Manufacturing

Argos

Not disclosed

Not disclosed

07

DimoMaint acquired Camileia

TMT

DimoMaint

Not disclosed

Not disclosed

The rumour mill

Industry news

Salaries and bonuses

Job moves

Market trends

The mid-market health check

Baker Tilly’s global healthcare M&A report shows deal value up 38% to $546.7bn in 2025, yet volume fell 5%, a divergence that captures the market precisely: fewer deals, larger tickets. The mid-market followed the same pattern, with value growing 2% to $105bn while volume contracted 3%, underperforming a broader mid-market that managed 4% volume growth across all sectors.

The value-volume gap points to tightening asset supply and rising average deal sizes, particularly in digital health and specialty pharma. Structural tailwinds remain intact for 2026, with large portfolio carve-outs sustaining a pipeline of mid-sized targets, but a broad volume recovery looks more likely in the back half of the year than the first.

Dealmakers mean business in 2026

KPMG’s latest dealmaker survey puts 96% of respondents in the market for at least one transaction this year, with a mean of 5.75 deals per organisation. The volume data points to committed pipelines rather than cautious toe-dipping. 

The dominant cohort, 36%, is targeting three to four deals, a cadence that speaks to programmatic discipline over opportunism, while 23% are planning five or more, suggesting a meaningful segment of the market is treating 2026 as an acceleration, not merely a recovery.

A quiet March, with caveats

March was a quiet month for UK public M&A by any recent measure, according to Herbert Smith Freehills. Three firm offers were announced, down from seven in March 2025 and the lowest March figure in at least four years. Possible offers held up somewhat better, remaining broadly in line with 2022 to 2024 levels, though well short of last year’s 11. 

The headline deals included Zurich Insurance Group’s recommended £8.1bn cash offer for Beazley and a hostile £221m bid for CAB Payments, which also attracted a separate possible offer from StoneX at £241.4m.

   

Stay in the loop on M&A rumors and news Subscribe to M&A Teaser